Australia - angielski - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - sodium ascorbate, quantity: 300 mg/ml - injection, solution - excipient ingredients: water for injections - for the treatment of vitamin c deficiency when oral treatment is not feasible.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - sodium ascorbate, quantity: 15 g; disodium edetate, quantity: 3 g - injection, powder for - excipient ingredients: ethanol absolute - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) 1. disodium edetate is particularly effective in treating lead accumulation and lead poisoning. this is especially so where there is a concomitant hypercalcaemic problem (refer "indications (2)"). however it must be noted that disodium edetate is equally effective with calcium disodium edetate in removing heavy metals, even in the absence of hypercalcaemia. for patients with elevated serum calcium or hypermobility of their body pools of calcium where there may be transiently or prolonged raised serum calcium (see "indications (2)"), the edta of choice for removing heavy metals may be disodium edetate. there are no recognised safe limits for lead intoxication. lead poisoning may occur by ingestion or inhalation of lead dust or fumes. poisoning is manifested by a metallic taste, anorexia, irritability, apathy, abdominal colic, vomiting, diarrhoea, cons

Australia - angielski - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - sodium ascorbate, quantity: 15 g; disodium edetate, quantity: 3 g - injection, powder for - excipient ingredients: - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) 1. disodium edetate is particularly effective in treating lead accumulation and lead poisoning. this is especially so where there is a concomitant hypercalcaemic problem (refer "indications (2)"). however it must be noted that disodium edetate is equally effective with calcium disodium edetate in removing heavy metals, even in the absence of hypercalcaemia. for patients with elevated serum calcium or hypermobility of their body pools of calcium where there may be transiently or prolonged raised serum calcium (see "indications (2)"), the edta of choice for removing heavy metals may be disodium edetate. there are no recognised safe limits for lead intoxication. lead poisoning may occur by ingestion or inhalation of lead dust or fumes. poisoning is manifested by a metallic taste, anorexia, irritability, apathy, abdominal colic, vomiting, diarrhoea, cons

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

deremetrx llc - sodium ascorbate (unii: s033eh8359) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), tocophersolan (unii: o03s90u1f2) (tocophersolan - unii:o03s90u1f2), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), folic acid (unii: - sodium ascorbate 120 mg - indications and usage:  pre-tabs dha is indicated to provide vitamin/mineral and omega-3 fatty acid supplementation to women throughout pregnancy, during the postnatal for both lactating and nonlactating mothers. pre-tabs dha is also beneficial in improving the nutritional status of women prior to conception. contraindications: this product is contraindicated in patients with a known hypersensitivity to any of the ingredients .

Australia - angielski - Department of Health (Therapeutic Goods Administration)

melrose laboratories pty ltd - sodium ascorbate, quantity: 1 g/g (equivalent: ascorbic acid, qty 880 mg/g) - powder, oral - excipient ingredients: - antioxidant/reduce free radicals formed in the body ; helps enhance/promote collagen formation ; maintain/support collagen health ; maintain/support eye health ; maintain/support general health and wellbeing ; maintain/support gum health ; maintain/support healthy teeth ; maintain/support connective tissue health ; maintain/support bone health ; aids/assists healthy bone development/growth/building ; helps maintain/supports healthy joint cartilage growth/development/production ; maintain/support blood capillary health ; helps reduce occurrence of symptoms of mild allergies ; maintain/support immune system health ; maintain/support healthy immune system function ; helps enhance/promote/increase absorption of dietary (state vitamin/mineral/nutrient) ; maintain/support (state vitamin/mineral/nutrient) levels in the body ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; decrease/reduce/relieve common cold duration ; helps decrease/reduce/relieve the severi

Australia - angielski - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - sodium ascorbate, quantity: 300 mg/ml - injection, intravenous infusion - excipient ingredients: water for injections - sodium ascorbate solution injection for intravenous infusion is indicated for the treatment of vitamin c deficiency when oral treatment is not feasible.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - sodium ascorbate, quantity: 113 mg (equivalent: ascorbic acid, qty 100 mg); folic acid, quantity: 0.4 mg; pyridoxine hydrochloride, quantity: 4.9 mg (equivalent: pyridoxine, qty 4 mg); nicotinamide, quantity: 40 mg; cyanocobalamin, quantity: 5 microgram; thiamine nitrate, quantity: 3.1 mg; biotin, quantity: 60 microgram; sodium pantothenate, quantity: 16.5 mg (equivalent: pantothenic acid, qty 15 mg); riboflavine sodium phosphate, quantity: 4.9 mg (equivalent: riboflavine, qty 3.6 mg) - injection, powder for - excipient ingredients: edetate sodium; methyl hydroxybenzoate; glycine - soluvit n is intended as a supplement in intravenous nutrition in order to meet the daily requirements of the water-soluble vitamins in adults, adolescents, children and infants. fat-soluble vitamins should also be administered to patients receiving prolonged parenteral nutrition.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - sodium ascorbate, quantity: 250 mg/ml - injection, solution - excipient ingredients: water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) sodium ascorbate injections are indicated for the treatment of vitamin c deficiency when oral treatment is not feasible

Australia - angielski - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - sodium ascorbate, quantity: 250 g/l - injection, intravenous infusion - excipient ingredients: water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) sodium ascorbate injections are indicated for the treatment of vitamin c deficiency when oral treatment is not feasible

Australia - angielski - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - sodium ascorbate, quantity: 250 g/l - injection, intravenous infusion - excipient ingredients: water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) sodium ascorbate injections are indicated for the treatment of vitamin c deficiency when oral treatment is not feasible